Gates Package — page 241

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl 2022-1187 Gift 6/22/2020] 6/30/2024|National Multiple Sclerosis Society Faraniz Safavi 2022-1233 Letter of Intent/MOU 11/30/2022 Vaccigen, SAS, VaxThera, SAS Bernard Moss 2022-1287 CTA - Clinical Trial Agreement 6/20/2023 Sanofi Pasteur S.A. H Clifford Lane 2022-1289 Gift 3/23/2023] 11/29/2024 |American Society of Tropical Medicine & Hygiene 2022-1289 Gift 3/23/2023] 11/29/2024 |American Society of Tropical Medicine & Hygiene Christina Yek 2022-1289 Gift 3/23/2023] 11/29/2024 |American Society of Tropical Medicine & Hygiene C-008-2014 CRADA 1/20/2015) Knopp Biosciences, LLC Amy Klion C-020-2024 CRADA 10/11/2023] 10/11/2027 |Neolmmunetech, Inc. [US] Andrea Lisco C-020-2024 CRADA 10/11/2023] 10/11/2027 |Neolmmunetech, Inc. [US] Andrea Lisco C-032-2014 CRADA 3/29/2017, Janssen Research and Development C-035-2023 CRADA 1/12/2023] _6/25/2023}PharmAbcine Kirk Druey C-053-2021 CRADA 11/10/2021 Amgen, Inc. C-084-2023 CRADA 8/23/2023] 8/23/2026|Imunon, Inc. Heinrich Feldmann C-084-2023 CRADA 8/23/2023] 8/23/2026|imunon, Inc. Heinrich Feldmann C-100-2020 CRADA 9/24/2021 AstraZeneca Pharmaceuticals LP Amy Klion C-129-2023 CRADA 12/1/2023] 12/1/2028] Viracta Therapeutics, Inc. Jeffrey Cohen C-137-2023 CRADA 9/25/2023] 9/25/2025|MacroGenics, Inc. Ethan Shevach C-137-2023 CRADA 9/25/2023] 9/25/2025|MacroGenics, Inc. Ethan Shevach C-156-2023 CRADA 11/2/2023] _11/2/2028}GlaxoSmithKline Clifton Barry C-162-2023 CRADA 9/27/2023] 9/27/2025|Leyden Laboratories B.V. Joshua Tan C-163-2023 CRADA 10/11/2023] 10/11/2026] PARI Pharma GmBH Peter Sun C-164-2023 CRADA 7/14/2023} 7/14/2025|Dartmouth College, Exothera [BE] Mark Connors C-2019-0227_ |CRADA 7/11/2023} _6/25/2024|F2G Ltd. [GB] Steven Holland T-00057-2023 |Research Collaboration Agreement 8/10/2023] 8/11/2025|ModernaTX, Inc. Jeffrey Cohen T-00143-2024 |CTA - Clinical Trial Agreement 10/18/2023 TFF Pharmaceuticals Inc. Alexandra Freema T-00202-2023 |Research Collaboration Agreement 4/14/2023] 4/14/2033]|Yale University Rachel Sparks T-00203-2023 |CTA - Clinical Trial Agreement 5/6/2023} CellScript, LLC Suk See DeRavin Stellenbosch University (Universiteit Stellenbosch) T-00303-2024 |Research Collaboration Agreement 12/13/2023] 12/13/2025} [ZA] Michal Fried T-00467-2023 |Research Collaboration Agreement 2/25/2023] 2/25/2024|New Mexico State University Joel Vega-rodrigue| Eugenia Lo, The University of North Carolina at T-00471-2023 |Research Collaboration Agreement 3/3/2023 3/3/2024] Charlotte Louis Miller Post Graduate Institute of Medical Education and T-00509-2023 |Letter of Intent/MOU 11/19/2022 Research Michail Lionakis